SE431550B - Forfarande for framstellning av en ogiftig polymer omfattande nikotinsyraradikaler bundna till sterkelse - Google Patents

Forfarande for framstellning av en ogiftig polymer omfattande nikotinsyraradikaler bundna till sterkelse

Info

Publication number
SE431550B
SE431550B SE7603070A SE7603070A SE431550B SE 431550 B SE431550 B SE 431550B SE 7603070 A SE7603070 A SE 7603070A SE 7603070 A SE7603070 A SE 7603070A SE 431550 B SE431550 B SE 431550B
Authority
SE
Sweden
Prior art keywords
nichotic
poisonous
starch
preparing
procedure
Prior art date
Application number
SE7603070A
Other languages
English (en)
Swedish (sv)
Other versions
SE7603070L (sv
Inventor
Paolo Ferruti
Rodolfo Paoletti
Lina Puglisi
Original Assignee
Paolo Ferruti
Rodolfo Paoletti
Lina Puglisi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Paolo Ferruti, Rodolfo Paoletti, Lina Puglisi filed Critical Paolo Ferruti
Publication of SE7603070L publication Critical patent/SE7603070L/xx
Publication of SE431550B publication Critical patent/SE431550B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B31/00Preparation of derivatives of starch
    • C08B31/02Esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F8/00Chemical modification by after-treatment
    • C08F8/30Introducing nitrogen atoms or nitrogen-containing groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pyridine Compounds (AREA)
SE7603070A 1974-10-15 1976-03-08 Forfarande for framstellning av en ogiftig polymer omfattande nikotinsyraradikaler bundna till sterkelse SE431550B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT28420/74A IT1044798B (it) 1974-10-15 1974-10-15 Alti polimeri contenenti acido nicotinico processo per la loro preparazione e loro impiego

Publications (2)

Publication Number Publication Date
SE7603070L SE7603070L (sv) 1977-09-09
SE431550B true SE431550B (sv) 1984-02-13

Family

ID=11223568

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7603070A SE431550B (sv) 1974-10-15 1976-03-08 Forfarande for framstellning av en ogiftig polymer omfattande nikotinsyraradikaler bundna till sterkelse

Country Status (7)

Country Link
US (1) US4067876A (xx)
JP (1) JPS52114688A (xx)
DE (1) DE2546242A1 (xx)
FR (1) FR2346016A1 (xx)
GB (3) GB1526795A (xx)
IT (1) IT1044798B (xx)
SE (1) SE431550B (xx)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4166902A (en) * 1974-10-14 1979-09-04 Paolo Ferruti High polymers containing nicotinic acid, process for their preparation and their use
US4169923A (en) * 1974-10-15 1979-10-02 Paolo Ferruti High polymers containing nicotinic acid, process for their preparation and their use
US4515658A (en) * 1984-08-20 1985-05-07 Nalco Chemical Company Retention aids
DE3700308A1 (de) * 1987-01-08 1988-07-21 Hoechst Ag Reversibel ausfaellbare, wasserloesliche polymerkonjugate, ihre herstellung und verwendung in der homogenen katalyse
US5310786A (en) * 1987-01-08 1994-05-10 Hoechst Aktiengesellschaft Reversibly precipitable, water-soluble polymer conjugates
US6129930A (en) * 1993-09-20 2000-10-10 Bova; David J. Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night
US6818229B1 (en) 1993-09-20 2004-11-16 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia
US20080045573A1 (en) * 1993-09-20 2008-02-21 Bova David J Methods and Sustained Release Nicotinic Acid Compositions for Treating Hyperlipidemia
US6080428A (en) * 1993-09-20 2000-06-27 Bova; David J. Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
US20060263428A1 (en) * 1993-09-20 2006-11-23 Eugenio Cefali Methods for treating hyperlipidemia with intermediate release nicotinic acid compositions having unique biopharmaceutical characteristics
US6746691B2 (en) 1993-09-20 2004-06-08 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics
US6676967B1 (en) 1993-09-20 2004-01-13 Kos Pharmaceuticals, Inc. Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
ZA978537B (en) 1996-09-23 1998-05-12 Focal Inc Polymerizable biodegradable polymers including carbonate or dioxanone linkages.
JP2002508758A (ja) 1997-06-12 2002-03-19 エムエル・ラボラトリーズ・パブリック・リミテッド・カンパニー 生物的に活性な材料
US7736636B2 (en) * 2003-02-12 2010-06-15 Shaker Mousa Method for treating occlusive vascular diseases & wound healing
WO2015006679A2 (en) 2013-07-11 2015-01-15 Aqua Turf International, Inc. Air filtration mask with opening front cover

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2701244A (en) * 1953-06-12 1955-02-01 Chemstrand Corp Method for rendering acrylonitrile polymers dye-receptive

Also Published As

Publication number Publication date
GB1527351A (en) 1978-10-04
JPS5324471B2 (xx) 1978-07-20
SE7603070L (sv) 1977-09-09
IT1044798B (it) 1980-04-21
FR2346016B1 (xx) 1979-10-05
DE2546242A1 (de) 1976-04-29
US4067876A (en) 1978-01-10
JPS52114688A (en) 1977-09-26
FR2346016A1 (fr) 1977-10-28
GB1526795A (en) 1978-09-27
GB1526720A (en) 1978-09-27

Similar Documents

Publication Publication Date Title
SE420199B (sv) Forfarande for framstellning av 16-oxiderade prostansyraderivat
NO142401C (no) Analogifremgangsmaate til fremstilling av mavesyresekresjonshemmende 2-pyridylalkyltiobenzimidazoler
SE439649B (sv) Forfarande for framstellning av en partikelinnehallande fiberarkprodukt
SE423633B (sv) Forfarande for framstellning av 4-demetoxi-daunomycin
SE425508B (sv) Kontinuerligt forfarande for sonderdelning av ett polysackaridhaltigt raemne medelst syrahydrolys
SE431550B (sv) Forfarande for framstellning av en ogiftig polymer omfattande nikotinsyraradikaler bundna till sterkelse
SE431652B (sv) Forfarande for framstellning av 7beta-amino-3cefem-3ol-4-karboxylsyraderivat
SE7510812L (sv) Sett att framstella ett nukleasresistent hydrofilt komplex av polyriboinosin-polyribocytidyl-syra
SE431211B (sv) Forfarande for framstellning av n-acylamino-alfa-arylacetamido-cefalosporiner
FI52876C (fi) Foerfarande foer tvaettning av en cellulosamassa fraon alkalikok
SE421612B (sv) Forfarande for framstellning av alfa-6-deoxi-5-hydroxitetracyklin
SE421921B (sv) Analogiforfarande for framstellning av pyridobensodiazepinoner
SE422800B (sv) Forfarande for framstellning av 6-d-(-)-alfa-amino-alfa(p-acetoxifenylacetamido) penicillansyra
SE418292B (sv) Forfarande for framstellning av 5-aryl-2-furamidiner
NO141050C (no) Fremgangsmaate ved fremstilling av 5-fluor-2-methyl-1-(p-methylsulfinylbenzyliden)-ind-2-en-3-yl-eddiksyre
SE419252B (sv) Anordning for tillverkning av trekonstruktioner
DK513375A (da) Berer til immunokemiske malinger
SE400960B (sv) Forfarande for framstellning av alhŸ3 (poŸ4)Ÿ2 3hŸ2o
SE431983B (sv) Sett att framstella 15-etylendioxiprostansyraderivat
SE414926B (sv) Forfarande for framstellning av 1-alkyl-2-(fenoximetyl)-5-nitroimidazoler
SE422210B (sv) Analogiforfarande for framstellning av substituerade indoler
SE424316B (sv) Forfarande for framstellning av en kanelsyraamid
NO146677C (no) Fremgangsmaate for fortykning av en loesning av et filmdannende polymermateriale.
SE415658B (sv) Analogiforfarande for framstellning av linnolinderivat
SE7503607L (sv) Forfarande for framstellning av en foregangsform av teofyllin.